Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meik Kunz

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Frontiers in Cardiovascular Medicine|July 5, 2022
Deciphering Pro-angiogenic Transcription Factor Profiles in Hypoxic Human Endothelial Cells by Combined Bioinformatics and <i>in vitro</i> ModelingArne Schmidt, Maximilian Fuchs, Stevan D Stojanović, et al.
Frontiers in Immunology|January 1, 2024
Soluble CD83 modulates human-monocyte-derived macrophages toward alternative phenotype, function, and metabolismKatrin Peckert-Maier, Andreas B Wild, Laura Sprißler, et al.
Scientific Reports|June 15, 2021
Reconstruction of the miR-506-Quaking axis in Idiopathic Pulmonary Fibrosis using integrative multi-source bioinformaticsStevan D Stojanović, Maximilian Fuchs, Chunguang Liang, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
A PLURIPOTENT STEM CELL PLATFORM FOR IN VITRO SYSTEMS GENETICS STUDIES OF MOUSE DEVELOPMENTRachel A Glenn, Stephanie C Do, Karthik Guruvayurappan, et al.
Frontiers in Immunology|August 25, 2022
The soluble CD83 protein prevents bone destruction by inhibiting the formation of osteoclasts and inducing resolution of inflammation in arthritisDmytro Royzman, Darja Andreev, Lena Stich, et al.
Annals of the Rheumatic Diseases|April 9, 2024
Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosisCaitríona Grönberg, Sara Rattik, Cuong Tran-Manh, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 18, 2023
Effect of Anti-S100A4 Monoclonal Antibody Treatment on Experimental Skin Fibrosis and Systemic Sclerosis-Specific Transcriptional Signatures in Human SkinThuong Trinh-Minh, Andrea-Hermina Györfi, Michal Tomcik, et al.
ALTEX|December 14, 2020
Modular micro-physiological human tumor/tissue models based on decellularized tissue for improved preclinical testingJohanna Kühnemundt, Heidi Leifeld, Florian Scherg, et al.
Annals of the Rheumatic Diseases|September 29, 2023
L-arginine metabolism inhibits arthritis and inflammatory bone lossShan Cao, Yixuan Li, Rui Song, et al.
Frontiers in Immunology|October 17, 2022
Soluble CD83 improves and accelerates wound healing by the induction of pro-resolving macrophagesDmytro Royzman, Katrin Peckert-Maier, Lena Stich, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Cardiovascular Medicine|July 5, 2022
Deciphering Pro-angiogenic Transcription Factor Profiles in Hypoxic Human Endothelial Cells by Combined Bioinformatics and <i>in vitro</i> ModelingArne Schmidt, Maximilian Fuchs, Stevan D Stojanović, et al.
Frontiers in Immunology|January 1, 2024
Soluble CD83 modulates human-monocyte-derived macrophages toward alternative phenotype, function, and metabolismKatrin Peckert-Maier, Andreas B Wild, Laura Sprißler, et al.
Scientific Reports|June 15, 2021
Reconstruction of the miR-506-Quaking axis in Idiopathic Pulmonary Fibrosis using integrative multi-source bioinformaticsStevan D Stojanović, Maximilian Fuchs, Chunguang Liang, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
A PLURIPOTENT STEM CELL PLATFORM FOR IN VITRO SYSTEMS GENETICS STUDIES OF MOUSE DEVELOPMENTRachel A Glenn, Stephanie C Do, Karthik Guruvayurappan, et al.
Frontiers in Immunology|August 25, 2022
The soluble CD83 protein prevents bone destruction by inhibiting the formation of osteoclasts and inducing resolution of inflammation in arthritisDmytro Royzman, Darja Andreev, Lena Stich, et al.
Annals of the Rheumatic Diseases|April 9, 2024
Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosisCaitríona Grönberg, Sara Rattik, Cuong Tran-Manh, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 18, 2023
Effect of Anti-S100A4 Monoclonal Antibody Treatment on Experimental Skin Fibrosis and Systemic Sclerosis-Specific Transcriptional Signatures in Human SkinThuong Trinh-Minh, Andrea-Hermina Györfi, Michal Tomcik, et al.
ALTEX|December 14, 2020
Modular micro-physiological human tumor/tissue models based on decellularized tissue for improved preclinical testingJohanna Kühnemundt, Heidi Leifeld, Florian Scherg, et al.
Annals of the Rheumatic Diseases|September 29, 2023
L-arginine metabolism inhibits arthritis and inflammatory bone lossShan Cao, Yixuan Li, Rui Song, et al.
Frontiers in Immunology|October 17, 2022
Soluble CD83 improves and accelerates wound healing by the induction of pro-resolving macrophagesDmytro Royzman, Katrin Peckert-Maier, Lena Stich, et al.
Pageof 7